Futura Medical Release: Appointment of Adviser on Pain Relief

Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for the consumer healthcare market, is pleased to announce the appointment of Professor Robert Moore DSc as an advisory consultant to the Company in the therapeutic area of pain relief. Prof Moore's extensive experience of pain relief, from both academic and commercial perspectives, is expected to be of great value in the development of TPR100, Futura's topical treatment for the provision of pain relief.

Back to news